Kidney Disease Management
eBook - ePub

Kidney Disease Management

A Practical Approach for the Non-Specialist Healthcare Practitioner

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Kidney Disease Management

A Practical Approach for the Non-Specialist Healthcare Practitioner

Book details
Book preview
Table of contents
Citations

About This Book

Kidney Disease Management

"This informative book has been put together with the support and input of many clinical renal experts, who have been willing to share their knowledge and years of experience and I'm sure it will be an excellent resource for those caring for kidney patients for the first time – as well as for those with some years of experience!"

From the Foreword by Rosemary Macri, Chief Executive of the British Kidney Patient Association

Kidney Disease Management: A Practical Approach for the Non-Specialist Healthcare Practitioner has been written to help optimise the care of people with chronic kidney disease (CKD) across the healthcare spectrum. It is aimed at a range of professionals, including nurses, junior doctors, general practitioners, pharmacists and dietitians. Specialists in training may also find it useful. It highlights the practical considerations necessary to care for people with kidney problems in situations where a specialist practitioner is not always required or immediately available.

This book explores policy context and CKD, overview of CKD and management, managing CKD in primary care, treatment modalities in CKD, psychosocial aspects of living with CKD, acute kidney injury in hospitalised patients, surgery and kidney injury, medication management in CKD, nutrition and CKD, and support and palliative care for people with CKD.

Key features:

  • Based on best practice and written in an accessible format aimed at busy practitioners
  • Emphasises the centrality of the patient and family and the need to share information and expertise across traditional boundaries
  • Written by professionals renowned in their field, both generalists and specialists, who have extensive experience of the practicalities of managing complex patients

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Kidney Disease Management by Rachel Lewis, Helen Noble in PDF and/or ePUB format, as well as other popular books in Medicine & Clinical Medicine. We have over one million books available in our catalogue for you to explore.

Information

Year
2012
ISBN
9781118490778
Edition
1

Chapter 1

Managing Chronic Conditions: The Policy Context

Beverley Matthews
NHS Kidney Care and Liver Care, UK

Introduction

The rising incidence and prevalence of chronic conditions presents a serious challenge to the effectiveness and sustainability of current and future healthcare services. A major issue is the increasing number of people with multiple chronic conditions and health services that continue to be organised around specific diseases. It is evident that chronic kidney disease (CKD) encompasses a spectrum of health states, and that these can be negatively affected by other chronic conditions and age-related problems such as memory impairment and mobility issues. Similarly, socioeconomic factors such as deprivation also adversely influence health outcomes. In effectively meeting the diverse needs of people with chronic conditions, a population management approach is required whereby the focus of care is based on the level of need and extends beyond traditional disease-specific approaches. Successive health policies reflect this shift with initiatives such as ‘Our health, our care, our say’ (Department of Health 2006) and the long-term conditions National Service Framework (Department of Health 2005) aimed at services being delivered through a ‘whole systems approach’. Continuity of care is required across ­traditional organisational boundaries through more effective collaboration of professionals. Key to this approach is engaging and supporting the patient in self-management. This chapter provides an overview of the changing context of healthcare services, including the innovative work of NHS Kidney Care in working across healthcare sectors and the current policy work which supports a more integrated and collaborative approach in supporting people with chronic kidney disease.

Chronic kidney disease in context

The effective management of chronic or long-term conditions poses a significant challenge for healthcare systems across the world. In England, around 15 million people have a long-term condition. While the number of ­people in England is likely to remain relatively steady, the number of people with multiple chronic conditions is expected to rise by a third over the next 10 years. People with long-term conditions account for 29% of the population in England, but are the most frequent users of healthcare services, accounting for 50% of all general practice appointments and 70% of all inpatient bed days. It is estimated that the treatment and care of those with long-term ­conditions accounts for 70% of the primary and acute care budget in England. This means around one-third of the population accounts for over two-thirds of the spend (Department of Health 2011). More significant than the impact on resources is the effect that long-term conditions have on quality of life. Each year around 170 000 people die prematurely in England, with the main causes being cancers and circulatory diseases. The proportion of people with a ­limiting long-term condition in work is a third lower than among those without (Department of Health 2011).
Healthcare services continue to be organised around specific conditions. Even for people with a single chronic condition, care is typically provided across a number of different health professionals and organisations. The resultant discontinuity and fragmentation of care can add to an already high disease burden (Nolte & McKee 2008) at the same time as increasing care costs through the duplication of interventions, omissions in treatment and miscommunication. Patient safety is also threatened (Boerma 2006). Whilst improvement initiatives have typically focused on optimising the clinical aspects of chronic care, this alone has not been as effective as wider initiatives that have included service redesign (Coleman et al. 2009, Curry & Ham 2010, Goodwin et al. 2012). How and where care is provided has important implications for the effectiveness and sustainability of long-term care, and strong primary care is considered to be central to improving patient outcomes and controlling costs (Roland et al. 2007). Patient-centred care, self-management support, improved continuity and coordination have all been identified as key contributors of quality in chronic care but can only be delivered through patients, professionals and organisations working more collaboratively together (Wagner 1996, Greaves & Campbell 2007).
Chronic kidney disease (CKD) describes abnormal kidney function and/or structure. It is common, frequently unrecognised, and it often exists together with other conditions (for example, cardiovascular disease and diabetes). The risk of developing CKD increases with age, and some conditions that coexist with CKD become more severe as kidney dysfunction advances. CKD covers a spectrum of health states including an asymptomatic period which is potentially detectable. Tests for CKD are both simple and widely available, and there is evidence that treatment can prevent or delay progression, reduce or ­prevent the development of complications and reduce the risk of cardiovascular ­disease. In cases where progression cannot be prevented, kidney function may deteriorate to stage 5, requiring life-saving dialysis, a kidney transplant or ­conservative management.
Estimates suggest that there about 4.5 million people in England with CKD. Since 2006, the prevalence of CKD has been reported annually in general practice and has seen a steady rise from 3% to 4.3% in 2009/10. However, compared with an estimated prevalence of 8.8%, diagnosis and ascertainment nationally is still only around half of the expected prevalence. Overall, there are an estimated 1.95 million people in England with undiagnosed CKD, who are therefore untreated and at risk of faster disease progression.

The policy context

In 2010, the UK government set out its long-term vision for the future of the National Health Service (NHS) and health services in England in the NHS White Paper, Equity and Excellence: Liberating the NHS. It committed to put the patient at the heart of services through greater choice and control including:
  • greater shared decision making and the principle of ‘no decision about me without me’
  • greater choice of treatment and access to information
  • a focus on personalised care that reflects individuals’ health and care needs, supports carers and encourages strong joint arrangements and local ­partnerships
Legislation to support this policy direction has since been enacted in the Health and Social Care Act (2012). The White Paper also committed the NHS to focus on outcomes and the quality standards that deliver them. The government’s objectives are to reduce mortality and morbidity, increase safety, and improve patient experience and outcomes for all. To this end, quality standards, developed by the National Institute for Health and Clinical Excellence (NICE), will inform the commissioning of all NHS care.
This approach builds upon and develops further the improvements achieved by the implementation of the National Service Frameworks (NSFs). The NSFs set clear quality requirements for care, based on the best evidence of what treatments and services work most effectively, seeking to ensure an equity of services irrespective of where they are delivered. The NSF for renal services (Department of Health 2004–05) placed a strong emphasis on identifying the condition early in primary care settings, slowing down its progress and minimising its impact on people’s lives. It led to significant improvements in the way kidney disease is managed. The NICE quality standards take this further and are a set of specific, concise statements that act as markers of high-­quality, cost-effective patient care, covering the treatment and prevention of different diseases and conditions. Derived from the best available evidence such as NICE guidance and other accredited sources, they are developed ­independently by NICE in collaboration with the NHS, social care professionals, their partners and service users. The quality standards are organised around five national outcome goals or domains, covering the breadth of NHS activity (Table 1.1), and they address the three dimensions of quality: clinical effectiveness, patient safety and patient experience. They enable:
Table 1.1 NHS Quality and Outcomes Framework: five domains, three dimensions.
Domain 1Preventing people from dying prematurely
Domain 2Enhancing quality of life for people with long-term conditionsEffectiveness
Domain 3Helping people to recover from episodes of ill health or following injury
Domain 4Ensuring people have a positive experience of careExperience
Domain 5Treating and caring for people in a safe environment and protecting them from avoidable harmSafety
© The Health and Social Care Information Centre.
  • health and social care professionals to make decisions about care based on the latest evidence and best practice
  • patients to understand what service they can expect from their health and social care providers
  • NHS trusts to quickly and easily examine the clinical performance of their organisation and assess the standards of care they provide
  • commissioners to be confident that the services they are providing are high quality and cost-effective
NICE published its quality standards for chronic kidney disease in 2011 (Table 1.2).
In addition to informing commissioning decisions, quality standards can also be aligned with the NHS funding system to encourage providers to follow best practice. In 2011, a best practice tariff for renal dialysis was introduced, paying significantly more for dialysis sessions that are delivered through definitive access (arteriovenous fistula or graft) than for those that are not. This is known to be better for patients because the faster flow rates result in more effective and efficient dialysis and it is much safer because of the reduced risk of infection. The level of the tariff was set so that providers with 75% (increased yearly by 5% to meet the Renal Association clinical guidelines of 85%) of their patients on definitive access would receive the same level of funding as under the previous system. In addition to rewarding services that do better than this, the tariff also provided a strong lever for those that were below this level to bring their services in line with best clinical guidance.
Table 1.2 NICE quality standards for chronic kidney disease.
National Institute for Health and Clinical Excellence (2011) ‘Chronic Kidney Disease quality standard’. London: NICE. Available from www.nice.org.uk. Reproduced with permission.
1People with risk factors for CKD are offered testing, and people with CKD are correctly identified.
2People with CKD who may benefit from specialist care are referred for specialist assessment in accordance with NICE guidance.
3People with CKD have a current agreed care plan appropriate to the stage and rate of progression of CKD.
4People with CKD are assessed for cardiovascular risk.
5People with higher levels of proteinuria, and people with diabetes and microalbuminuria, are enabled to safely maintain their systolic blood pressure within a target range 120–129 mmHg and their diastolic blood pressure below 80 mmHg.
6People with CKD are assessed for disease progression.
7People with CKD who become acutely unwell have their medication reviewed, and receive an assessment of volume status and renal function.
8People with anaemia of CKD have access to and receive anaemia treatment in accordance with NICE guidance.
9People with progressive CKD whose eGFR is less than 20 mL/min/1.73 m2, and/or who are likely to progress to established kidney failure within 12 months, receive unbiased personalised information on established kidney failure and renal replacement therapy options.
10People with established renal failure have access to psychosocial support (which may include support with personal, family, financial, employment and/or social needs) appropriate to their circumstances.
11People with CKD are support...

Table of contents

  1. Cover
  2. Title page
  3. Copyright page
  4. Contributors
  5. Foreword: David Colin-Thomé
  6. Foreword: Rosemary Macri
  7. Introduction: Managing Patients with Chronic Kidney Disease in Non-Specialist Areas: a Chronic Illness Approach
  8. Chapter 1: Managing Chronic Conditions: The Policy Context
  9. Chapter 2: What Non-Specialists Need to Know about Chronic Kidney Disease
  10. Chapter 3: A Practical Approach to Chronic Kidney Disease in Primary Care
  11. Chapter 4: General Considerations Related to Treatment Modalities
  12. Chapter 5: Psychosocial Aspects of Living with Chronic Kidney Disease
  13. Chapter 6: Acute Kidney Injury in Hospitalised Patients
  14. Chapter 7: Management of Patients with or at Risk of Kidney Disease on the Surgical Ward
  15. Chapter 8: Medication Management and Chronic Kidney Disease
  16. Chapter 9: Optimising Nutrition in People with Chronic Kidney Disease
  17. Chapter 10: Supportive and Palliative Care for Patients with Advanced Kidney Disease
  18. Index